References
- Mamelak AN, Jacoby DB. Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601). Expert Opin Drug Deliv. 2007 Mar;4(2):175–186.
- Goodenberger ML, Jenkins RB. Genetics of adult glioma. Cancer Genet. 2012 Dec;205(12):613–621.
- Cancer stat facts: brain and other nervous system cancer 2018. [cited 2019 Mar 30]. Available from: https://seer.cancer.gov/statfacts/html/brain.html
- Bush NA, Chang SM, Berger MS. Current and future strategies for treatment of glioma. Neurosurg Rev. 2017 Jan;40(1):1–14.
- Toms SA, Tapinos N. recent advances in the treatment of gliomas - comprehensive brain tumor center. R I Med J (2013). 2017 Jun 1;100(6):43–46.
- Khan Z, Suthanthiran M, Muthukumar T. MicroRNAs and Transplantation. Clin Lab Med. 2019 Mar;39(1):125–143.
- Gebert LFR, MacRae IJ. Regulation of microRNA function in animals. Nat Rev Mol Cell Biol. 2019 Jan;20(1):21–37.
- Ma S, Fu T, Zhao S, et al. MicroRNA-34a-5p suppresses tumorigenesis and progression of glioma and potentiates Temozolomide-induced cytotoxicity for glioma cells by targeting HMGA2. Eur J Pharmacol. 2019 Mar 6;852:42–50.
- Xia L, Nie D, Wang G, et al. FER1L4/miR-372/E2F1 works as a ceRNA system to regulate the proliferation and cell cycle of glioma cells. Journal of Cellular and Molecular Medicine. 2019 Mar 19;23:3224–3233.
- Pichler M, Stiegelbauer V, Vychytilova-Faltejskova P, et al. Genome-wide miRNA analysis identifies miR-188-3p as a novel prognostic marker and molecular factor involved in colorectal carcinogenesis. Clin Cancer Res off J Am Assoc Cancer Res. 2017 Mar 1;23(5):1323–1333.
- Song WY, Meng H, Wang XG, et al. Reduced microRNA-188-3p expression contributes to apoptosis of spermatogenic cells in patients with azoospermia. Cell Prolif. 2017;50:1.
- Zhang XF, Yang Y, Yang XY, et al. MiR-188-3p upregulation results in the inhibition of macrophage proinflammatory activities and atherosclerosis in ApoE-deficient mice. Thromb Res. 2018;171:55–61.
- Li N, Shi H, Zhang L, et al. miR-188 inhibits glioma cell proliferation and cell cycle progression through targeting beta-catenin. Oncol Res. 2018 Jun 11;26(5):785–794.
- Zhang J, Hu M, Teng Z. Synaptic and cognitive improvements by inhibition of 2-AG metabolism are through upregulation of microRNA-188-3p in a mouse model of Alzheimer’s disease. J Neurosci. 2014 Nov 5;34(45):14919–14933.
- Wei J, Wang F, Kong LY, et al. miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma. Cancer Res. 2013 Jul 1;73(13):3913–3926.
- Xiao ZQ, Yin TK, Li YX, et al. miR-130b regulates the proliferation, invasion and apoptosis of glioma cells via targeting of CYLD. Oncol Rep. 2017 Jul;38(1):167–174.
- Li S, Zeng A, Hu Q, et al. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas. Neuro Oncol. 2017 Jan;19(1):55–65.
- Lee DK, Lynch KR, Nguyen T, et al. Cloning and characterization of additional members of the G protein-coupled receptor family. Biochim Biophys Acta. 2000 Feb 29;1490(3):311–323.
- Kroeze WK, Sheffler DJ, Roth BL. G-protein-coupled receptors at a glance. J Cell Sci. 2003 Dec 15;116(Pt 24):4867–4869.
- Dhanasekaran N, Heasley LE, Johnson GL. G protein-coupled receptor systems involved in cell growth and oncogenesis. Endocr Rev. 1995 Jun;16(3):259–270.
- Boulay JL, Ionescu MC, Sivasankaran B, et al. The 10q25.3-26.1 G protein-coupled receptor gene GPR26 is epigenetically silenced in human gliomas. Int J Oncol. 2009 Nov;35(5):1123–1131.
- Carter AN, Cole CL, Playle AG, et al. GPR26: a marker for primary glioblastoma? Mol Cell Probes. 2008 Apr;22(2):133–137.
- Folts CJ, Giera S, Li T, et al. Adhesion G protein-coupled receptors as drug targets for neurological diseases. Trends Pharmacol Sci. 2019 Mar 11;40:278–293.
- Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017 Mar;16(3):203–222.
- Gilman AG. G proteins: transducers of receptor-generated signals. Annu Rev Biochem. 1987;56:615–649.
- Dong DD, Zhou H, Li G. GPR78 promotes lung cancer cell migration and metastasis by activation of Galphaq-Rho GTPase pathway. BMB Rep. 2016 Nov;49(11):623–628.
- Wang Y, Zhang J, Yang Y, et al. ROS generation and autophagosome accumulation contribute to the DMAMCL-induced inhibition of glioma cell proliferation by regulating the ROS/MAPK signaling pathway and suppressing the Akt/mTOR signaling pathway. Onco Targets Ther. 2019;12:1867–1880.